EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of human immunodeficiency virus-1 reverse transcriptase by thymoquinone and Nigella sativa extracts in vitro

Ayad M. Salem

Journal of Family and Community Medicine · 2026-10 · 33 (4) · 280-284

DOI: 10.4103/jfcm.jfcm_300_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Family and Community Medicine, online erschienen am 22.10.2026. Verfasst von Ayad M. Salem. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Reverse transcriptase (RT) enzyme inhibitors are used to treat human immunodeficiency virus (HIV). The aim of this study was to investigate the anti-HIV-RTenzyme activity of Nigella sativa (NS) and its active ingredient, thymoquinone (TQ). MATERIALS AND METHODS: Purified TQ and NS extract powder with 0.5% and 5% TQ were tested for their inhibition of HIV-1 RT in a biochemical assay using a nonradioactive HIV-RT enzyme-linked immunosorbent assay kit. Five dilutions of TQ (0.125, 0.25, 0.5, 1, and 2 mg/ml) were made and tested. The assay was conducted in triplicate, and doxorubicin was used as a positive control. The inhibition percentage and half-maximal inhibitory concentration (IC 50 ) values were calculated using Excel and GraphPad Prism software. Data were analyzed using SPSS. The TQ concentration–response relationship was analyzed by nonlinear regression using a four-parameter logistic model to estimate the IC50 and corresponding 95% confidence interval (CI). RESULTS: NS powders containing 0.5% TQ and 5% TQ showed a weak inhibitory effect on HIV-RT activity, with only 20% and 31% inhibition, respectively, which was significantly lower than the 89.6% inhibition in RT activity caused by the positive control (doxorubicin, P = 0.003 and P = 0.007, respectively). Purified TQ produced 82.5% inhibition of HIV-1 RT, whereas doxorubicin produced 89.6% inhibition; the difference between the two treatments did not reach statistical significance under the conditions of this assay ( P = 0.182). TQ exhibited anti-HIV-1 RT activity in a dose–response manner, with concentrations of 0.125 mg/ml, 0.25 mg/ml 0.5 mg/ml, 1 mg/ml, and 2 mg/ml produced 29%, 57.1%, 71.7%, 77.7%, and 82.5% inhibition in the HIV RT activity, respectively, with a calculated IC 50 value of 0.167 mg/mL (95% confidence interval: 0.147–0.190 mg/mL), corresponding to approximately 1.02 mM. CONCLUSION: Purified TQ demonstrated concentration-dependent inhibition of HIV-1 RT in the present in vitro enzyme assay. These findings provide preliminary biochemical evidence that supports further investigation of TQ as a potential inhibitor of HIV-1 RT.

Zitieren

APA

Salem, A. M. (2026). Inhibition of human immunodeficiency virus-1 reverse transcriptase by thymoquinone and Nigella sativa extracts in vitro. Journal of Family and Community Medicine, 33(4), 280-284. https://doi.org/10.4103/jfcm.jfcm_300_26

Vancouver

Salem AM. Inhibition of human immunodeficiency virus-1 reverse transcriptase by thymoquinone and Nigella sativa extracts in vitro. Journal of Family and Community Medicine. 2026;33(4):280-284. doi:10.4103/jfcm.jfcm_300_26

BibTeX
@article{Salem2026,
  author = {Salem, Ayad M.},
  title = {Inhibition of human immunodeficiency virus-1 reverse transcriptase by thymoquinone and Nigella sativa extracts in vitro},
  journal = {Journal of Family and Community Medicine},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {280--284},
  doi = {10.4103/jfcm.jfcm_300_26}
}
Kostenlos starten →